Eyenovia Inc (EYEN)
0.7499
-0.07
(-8.65%)
USD |
NASDAQ |
May 17, 16:00
0.7499
0.00 (0.00%)
After-Hours: 20:00
Eyenovia Free Cash Flow: -29.93M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | -29.93M |
December 31, 2023 | -27.81M |
September 30, 2023 | -27.06M |
June 30, 2023 | -26.49M |
March 31, 2023 | -25.47M |
December 31, 2022 | -25.98M |
September 30, 2022 | -26.59M |
June 30, 2022 | -25.23M |
March 31, 2022 | -25.97M |
December 31, 2021 | -22.49M |
September 30, 2021 | -10.75M |
June 30, 2021 | -7.148M |
March 31, 2021 | -5.552M |
Date | Value |
---|---|
December 31, 2020 | -6.646M |
September 30, 2020 | -16.20M |
June 30, 2020 | -18.09M |
March 31, 2020 | -19.20M |
December 31, 2019 | -19.09M |
September 30, 2019 | -19.05M |
June 30, 2019 | -18.72M |
March 31, 2019 | -16.62M |
December 31, 2018 | -13.11M |
September 30, 2018 | -11.01M |
June 30, 2018 | -8.249M |
March 31, 2018 | -6.251M |
December 31, 2017 | -4.741M |
Free Cash Flow Range, Past 5 Years
-29.93M
Minimum
Mar 2024
-5.552M
Maximum
Mar 2021
-20.17M
Average
-20.85M
Median
Free Cash Flow Benchmarks
NovaBay Pharmaceuticals Inc | -4.524M |
Alpine Immune Sciences Inc | -80.96M |
Lantern Pharma Inc | -13.67M |
Oragenics Inc | -7.291M |
MAIA Biotechnology Inc | -13.30M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -9.892M |
Cash from Investing (Quarterly) | -0.1141M |
Cash from Financing (Quarterly) | 3.133M |
Free Cash Flow Per Share (Quarterly) | -0.2147 |
Free Cash Flow to Equity (Quarterly) | -10.63M |
Free Cash Flow Yield | -92.14% |